2022 Q4 Form 10-Q Financial Statement

#000121390022071370 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue
YoY Change
Cost Of Revenue $341.5K
YoY Change
Gross Profit -$308.2K
YoY Change
Gross Profit Margin
Selling, General & Admin $133.9K
YoY Change
% of Gross Profit
Research & Development $3.262M
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.016M
YoY Change
Operating Profit -$13.41K -$19.19K
YoY Change -8.93% 34.35%
Interest Expense $34.11K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$34.11K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$13.41K -$19.19K
YoY Change -8.93% 34.35%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.000M shares 5.000M shares 5.000M shares
Diluted Shares Outstanding 5.000M shares 5.000M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $457.00 $1.268K $2.673K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $618.3K
Prepaid Expenses $81.34K
Receivables $23.70K
Other Receivables
Total Short-Term Assets $457.00 $1.268K $2.673K
YoY Change 68.63%
LONG-TERM ASSETS
Property, Plant & Equipment $3.376M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $457.00 $1.268K $2.673K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $457.00 $1.268K $2.673K
YoY Change 68.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $10.00K $10.00K
YoY Change 33.33%
Accrued Expenses $37.43K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $124.0K $113.9K $101.9K
YoY Change 71.13%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $124.0K $113.9K $101.9K
Total Long-Term Liabilities
Total Liabilities $124.0K $113.9K $101.9K
YoY Change 71.13%
SHAREHOLDERS EQUITY
Retained Earnings -$124.0K -$113.2K -$99.77K
YoY Change 70.65%
Common Stock $500.00 $500.00 $500.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$123.5K -$112.7K -$99.27K
YoY Change
Total Liabilities & Shareholders Equity $457.00 $1.268K $2.673K
YoY Change 68.63%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$13.41K -$19.19K
YoY Change -8.93% 34.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
dei Entity File Number
EntityFileNumber
000-56237
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5000000 shares
dei Entity Registrant Name
EntityRegistrantName
Patricia Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3844872
dei Entity Address Address Line1
EntityAddressAddressLine1
2255 Glades Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 324A
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
(561)
dei Local Phone Number
LocalPhoneNumber
989-2208
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1268 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1268 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
271 usd
CY2022Q3 us-gaap Assets
Assets
1268 usd
CY2021Q4 us-gaap Assets
Assets
271 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7500 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
103940 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
64960 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
113940 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72460 usd
CY2022Q3 us-gaap Liabilities
Liabilities
113940 usd
CY2021Q4 us-gaap Liabilities
Liabilities
72460 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113172 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72689 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-112672 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1268 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
271 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13405 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14720 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40483 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45221 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13405 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14720 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-40483 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-45221 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13405 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14720 usd
us-gaap Net Income Loss
NetIncomeLoss
-40483 usd
us-gaap Net Income Loss
NetIncomeLoss
-45221 usd
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-17562 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16217 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-33779 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14284 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-48063 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14720 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-62783 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7888 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-80077 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19190 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-99267 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13405 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-112672 usd
us-gaap Net Income Loss
NetIncomeLoss
-40483 usd
us-gaap Net Income Loss
NetIncomeLoss
-45221 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37983 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45221 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
38980 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
42460 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38980 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42460 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
997 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2761 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9438 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1268 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6677 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. <span style="text-decoration:underline">Nature of Operations</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective is to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officer and directors of the Company.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
patr Smaller Reporting Company Description
SmallerReportingCompanyDescription
The Company will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of the ordinary shares held by non-affiliates equals or exceeds $250 million as of the prior June 30, and (2) the annual revenues equaled or exceeded $100 million during such completed fiscal year or the market value of the ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30.
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23700 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15300 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
113100 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
72600 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.18 pure
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
103940 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
64960 usd
patr Net Income Loss Attributable To Parent
NetIncomeLossAttributableToParent
113172 usd
CY2022Q3 patr Working Capital Deficit
WorkingCapitalDeficit
112672 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
112672 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001832483

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-22-071370-index-headers.html Edgar Link pending
0001213900-22-071370-index.html Edgar Link pending
0001213900-22-071370.txt Edgar Link pending
0001213900-22-071370-xbrl.zip Edgar Link pending
f10q0922ex31-1_patriciaacq.htm Edgar Link pending
f10q0922ex32-1_patriciaacq.htm Edgar Link pending
f10q0922_patriciaacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
patr-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
patr-20220930_cal.xml Edgar Link unprocessable
patr-20220930_def.xml Edgar Link unprocessable
patr-20220930_pre.xml Edgar Link unprocessable
patr-20220930_lab.xml Edgar Link unprocessable
f10q0922_patriciaacq_htm.xml Edgar Link completed